http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016206235-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4383eff7d424f33a5252d6973036a564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate | 2016-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e43184b90aa3e2cd6a69c87633dada80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5faa896655218be0b917b36809762485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_accb69da438a66668605d89c10e8fee6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cd993e2949f90c692c25f8d95e0085b |
publicationDate | 2017-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2016206235-B2 |
titleOfInvention | Complexes of il-15 and il-15ralpha and uses thereof |
abstract | H:\ft\interwoven\NRPortbl\DCC\FMT\l0507844_ .docx-18/07/2016 The present invention relates to agents that modulate interleukin-15 ("IL-15") signal transduction or function ("Therapeutic Agents") and the use ol" those agents to modulate immune function. The Therapeutic Agents target the interaction between IL-15 and its receptor and modulate IL-15-induced signal transduction. The Therapeutic Agents may be formulated with polymers, such as poly-3- 1- +4-N-acetylglucosamine. for administration to a human subject to modulate IL-15-mediated immune function. |
priorityDate | 2007-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 3491.